BMJ

1. SCHUMMERS L, Cheng L, Odendaal M, Rodriguez-Llorian E, et al
   Effect of universal no-cost coverage on use of long-acting reversible contraception and all prescription contraception: population based, controlled, interrupted time series analysis.
   BMJ. 2025;390:e083874.
   

   >> Share

   
   

   
   Contraception

2. RODRIGUEZ MI, Rapp K, Burns H, Harper CC, et al
   Measuring contraceptive agency scale in the community.
   Contraception. 2025 Jul 26:111044. doi: 10.1016/j.contraception.2025.111044.
   

   >> Share

   
   
3. AFFANDI B, Korver T, Paul Geurts TB, Coelingh Bennink HJT, et al
   Retraction notice to "A pilot efficacy study with a single-rod contraceptive implant (Implanon(R)1) in 200 Indonesian women treated for
   Contraception. 2025 Jul 24:110999. doi: 10.1016/j.contraception.2025.110999.
   

   >> Share

   
   
4. QIAN J, Zhang Y, Li Y, Zhang Y, et al
   Barriers to Immediate Postpartum Long-Acting Reversible Contraceptive provision in China: A Qualitative Study from the Perspective of Service Providers.
   Contraception. 2025 Jul 23:111040. doi: 10.1016/j.contraception.2025.111040.
   

   >> Share

   
   
5. BRENNAND EA, Scime NV, Huang B, Randhawa A, et al
   Not here, not now: a mystery caller study of availability of mifepristone in community pharmacies in Alberta, Canada.
   Contraception. 2025;149:110945.
   

   >> Share

   
   

   
   Fertil Steril

6. DUIJKERS IJM, Klipping C, Draeger C, Schug BS, et al
   Inhibition of ovulation and pharmacologic mechanism of action of relugolix combination therapy.
   Fertil Steril. 2025;124:344-354.
   

   >> Share

   
   

   
   Horm Behav

7. BROOKE M, Graham BM
   Birth controlling your fears: The long-term effects of adolescent exposure to hormonal contraceptives on fear extinction in long-evans female rats.
   Horm Behav. 2025;174:105789.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share